Risk Factors of SARS-CoV-2 Antibodies in Arapahoe County First Responders—The COVID-19 Arapahoe SErosurveillance Study (CASES) Project
Authors:
- Katherine R. SabourinKSKatherine R. Sabourin
- Jonathan SchultzJSJonathan Schultz
- Joshua Bs RomeroJRJoshua Bs Romero
- Molly M. LambMLMolly M. Lamb
- Daniel LarremoreDLDaniel Larremore
- Thomas E. MorrisonTMThomas E. Morrison
- Ashley Frazer-AbelAFAshley Frazer-Abel
- Shanta ZimmerSZShanta Zimmer
- Ross M. KedlRKRoss M. Kedl
- Thomas JaenischTJThomas Jaenisch
- Rosemary RochfordRRRosemary Rochford
Open Access
- 3 December 2020
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Occupational and Environmental Medicine
- Vol. 63 (3) , 191-198
Abstract
Objectives: Define the seroprevalence and risk factors for SARS-CoV-2 antibodies in Arapahoe County, Colorado first responders (eg, law enforcement, human services, fire departments). Methods: Two hundred sixty four first responders were enrolled June to July 2020. SARS-CoV-2 seropositivity was defined as detection of immunoglobulin G (IgG) antibodies to both spike receptor binding domain and nucleocapsid in venous blood by validated enzyme-linked immunosorbent assay. We compared risk factors for being seropositive versus seronegative. Results: 4% (11/264) were SARS-CoV-2 seropositive. Seropositive participants were significantly more likely to have lung disease (% seropositive, % seronegative; P-value) (36%, 8%; P = 0.01), prior SARS-CoV-2/COVID-19 testing (36%, 8%; P ≤ 0.01), a prior positive result (18%, less than 1%), and to believe they previously had COVID-19 (64%, 15%; P < 0.01). Only 15% of those believing they had COVID-19 had anti-SARS-CoV-2 antibodies. Conclusions: Human services employees and individuals with lung disease are at SARS-CoV-2 exposure risk. Few individuals believed they had COVID-19 had prior exposure.Keywords
This publication has 29 references indexed in Scilit:
- Presymptomatic Transmission of SARS-CoV-2 — Singapore, January 23–March 16, 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility — King County, Washington, March 2020MMWR. Morbidity and Mortality Weekly Report, 2020
- Headaches Associated With Personal Protective Equipment – A Cross‐Sectional Study Among Frontline Healthcare Workers During COVID‐19Headache: The Journal of Head and Face Pain, 2020
- COVID-19 Transmission Within a Family Cluster by Presymptomatic Carriers in ChinaClinical Infectious Diseases, 2020
- Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)Clinical Infectious Diseases, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus diseaseChinese Medical Journal, 2020
- Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, ChinaAllergy, 2020
- Candida aurisIsolates Resistant to Three Classes of Antifungal Medications — New York, 2019MMWR. Morbidity and Mortality Weekly Report, 2020